Plain-English translation of NCT07552922 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is listening to men with prostate cancer to understand how they think about and experience breast-related side effects from hormone therapy treatments. The study will talk to two groups: men who haven't yet received this type of treatment, and men who have experienced these side effects firsthand. By learning what matters most to patients, researchers hope to help future patients make better-informed choices about their cancer care.
Some hormone therapies used to treat prostate cancer can cause unwanted breast-related side effects that really affect quality of life. This study exists to understand what trade-offs patients are willing to make—balancing cancer control against side effects and other life impacts—so that treatment decisions can be truly personalized to what matters most to each individual.
You likely qualify if…
You likely don't qualify if…
You will take part in a one-time semi-structured interview where a researcher will ask you thoughtful questions about your experiences with prostate cancer treatment and your concerns about side effects. The interview is designed to be a conversation—not a test—where your honest perspective is valued. This study does not involve taking any new medications or undergoing any medical procedures.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Australia
Sponsor
St Vincent's Hospital, Sydney
Collaborators
University of Technology, Sydney
Enrollment target
~24 participants
Started
December 2025
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in April 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.